Clinical utility of histological features of polyomavirus allograft nephropathy

Transplantation

Volumn 82, Issue 2, 2006, Pages 196-204

  Gaber, Lillian W ^a,c   Egidi, M Francesca ^a   Stratta, Robert J ^b   Lo, Agnes ^c,e   Moore, Linda W ^d   Gaber, A Osama ^a,f  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d METHODIST UNIVERSITY HOSPITAL   (United States)

^e GENZYME CORPORATION   (United States)

^f HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Chronic allograft nephropathy; Kidney transplantation; Kidney transplantation histology; Polyoma allograft nephropathy; Polyomavirus

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL FEATURE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; BIOPSY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; PANCREAS TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33746454651     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000226176.87700.a4     Document Type: Article

References (25)

1. Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257.
2. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1: 1253.
3. Coleman DV, Gardner SD, Field AM. Human polyomavirus infection in renal allograft recipients. BMJ 1973; 3: 371.
4. Gardner SD, MacKenzie EF, Smith C, Porter AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578.
5. Pappo O, Demetris AJ, Raikow RB, Randhawa PS. Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review. Mod Pathol 1996; 9: 105.
6. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918.
7. Hirsch HH. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2: 25.
8. Drachenberg RC, Drachenberg CB, Papadimitriou JC, et al. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant 2001; 1: 373.
9. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyoma virus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004; 4: 2082.
10. van Gorder MA, Della Pelle P, Henson JW, et al. Cynomolgus polyoma virus infection: a new member of the polyoma virus family causes interstitial nephritis, ureteritis, and enteritis in immunosuppressed cynomolgus monkeys. Am J Pathol 1999; 154: 1273.
11. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
12. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
13. Nickeleit V, Zeiler M, Gudat F, et al. Detection of the complement degradation product C4d in renal allgorafts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242.
14. Al-Jedai AH, Honaker MR, Trofe J, et al. Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation. Transplantation 2003; 75: 490.
15. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
16. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665.
17. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-Virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324.
18. Celik B, Shapiro R, Vats A, Randhawa PS. Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant 2003; 3: 1378.
19. Hussain S, Bresnahan BA, Cohen EP, Hariharan S. Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents. Clin Transplant 2002; 16: 43.
20. Ahuja M, Cohen EP, Dayer AM, et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71: 896.
21. Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213.
22. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103.
23. Dell'Antonio G, Randhawa PS. Striped pattern of medullary ray fibrosis in allograft biopsies from kidney transplant recipients maintained on tacrolimus. Transplantation 1999; 67: 484.
24. Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92: 373.
25. Haririan A, Hamze O, Drachenberg CB, et al. Polyomavirus reactivations in native kidneys of pancreas alone allograft recipients. Transplantation 2003; 75: 1186.